Global T-Cell Immunotherapy Sales Market Report 2017

Global T-Cell Immunotherapy Sales Market Report 2017

1 T-Cell Immunotherapy Overview

1.1 Product Overview and Scope of T-Cell Immunotherapy

1.2 Classification of T-Cell Immunotherapy

1.2.1 CAR-T

1.2.2 TCR

1.2.3 TIL Therapies

1.3 Application of T-Cell Immunotherapy

1.3.1 Hematological Malignancies

1.3.2 Solid Tumors

1.3.3 Others

1.4 T-Cell Immunotherapy Market by Regions

1.4.1 United States Status and Prospect (2012-2022)

1.4.2 China Status and Prospect (2012-2022)

1.4.3 Europe Status and Prospect (2012-2022)

1.4.4 Japan Status and Prospect (2012-2022)

1.4.5 Southeast Asia Status and Prospect (2012-2022)

1.4.6 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value and Volume) of T-Cell Immunotherapy (2012-2022)

1.5.1 Global T-Cell Immunotherapy Sales and Growth Rate (2012-2022)

1.5.2 Global T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

2 Global T-Cell Immunotherapy Competition by Manufacturers, Type and Application

2.1 Global T-Cell Immunotherapy Market Competition by Manufacturers

2.1.1 Global T-Cell Immunotherapy Sales and Market Share of Key Manufacturers (2012-2017)

2.1.2 Global T-Cell Immunotherapy Revenue and Share by Manufacturers (2012-2017)

2.2 Global T-Cell Immunotherapy (Volume and Value) by Type

2.2.1 Global T-Cell Immunotherapy Sales and Market Share by Type (2012-2017)

2.2.2 Global T-Cell Immunotherapy Revenue and Market Share by Type (2012-2017)

2.3 Global T-Cell Immunotherapy (Volume and Value) by Regions

2.3.1 Global T-Cell Immunotherapy Sales and Market Share by Regions (2012-2017)

2.3.2 Global T-Cell Immunotherapy Revenue and Market Share by Regions (2012-2017)

2.4 Global T-Cell Immunotherapy (Volume) by Application

3 United States T-Cell Immunotherapy (Volume, Value and Sales Price)

3.1 United States T-Cell Immunotherapy Sales and Value (2012-2017)

3.1.1 United States T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

3.1.2 United States T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

3.1.3 United States T-Cell Immunotherapy Sales Price Trend (2012-2017)

3.2 United States T-Cell Immunotherapy Sales and Market Share by Manufacturers

3.3 United States T-Cell Immunotherapy Sales and Market Share by Type

3.4 United States T-Cell Immunotherapy Sales and Market Share by Application

4 China T-Cell Immunotherapy (Volume, Value and Sales Price)

4.1 China T-Cell Immunotherapy Sales and Value (2012-2017)

4.1.1 China T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

4.1.2 China T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

4.1.3 China T-Cell Immunotherapy Sales Price Trend (2012-2017)

4.2 China T-Cell Immunotherapy Sales and Market Share by Manufacturers

4.3 China T-Cell Immunotherapy Sales and Market Share by Type

4.4 China T-Cell Immunotherapy Sales and Market Share by Application

5 Europe T-Cell Immunotherapy (Volume, Value and Sales Price)

5.1 Europe T-Cell Immunotherapy Sales and Value (2012-2017)

5.1.1 Europe T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

5.1.2 Europe T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

5.1.3 Europe T-Cell Immunotherapy Sales Price Trend (2012-2017)

5.2 Europe T-Cell Immunotherapy Sales and Market Share by Manufacturers

5.3 Europe T-Cell Immunotherapy Sales and Market Share by Type

5.4 Europe T-Cell Immunotherapy Sales and Market Share by Application

6 Japan T-Cell Immunotherapy (Volume, Value and Sales Price)

6.1 Japan T-Cell Immunotherapy Sales and Value (2012-2017)

6.1.1 Japan T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

6.1.2 Japan T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

6.1.3 Japan T-Cell Immunotherapy Sales Price Trend (2012-2017)

6.2 Japan T-Cell Immunotherapy Sales and Market Share by Manufacturers

6.3 Japan T-Cell Immunotherapy Sales and Market Share by Type

6.4 Japan T-Cell Immunotherapy Sales and Market Share by Application

7 Southeast Asia T-Cell Immunotherapy (Volume, Value and Sales Price)

7.1 Southeast Asia T-Cell Immunotherapy Sales and Value (2012-2017)

7.1.1 Southeast Asia T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

7.1.2 Southeast Asia T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

7.1.3 Southeast Asia T-Cell Immunotherapy Sales Price Trend (2012-2017)

7.2 Southeast Asia T-Cell Immunotherapy Sales and Market Share by Manufacturers

7.3 Southeast Asia T-Cell Immunotherapy Sales and Market Share by Type

7.4 Southeast Asia T-Cell Immunotherapy Sales and Market Share by Application

8 India T-Cell Immunotherapy (Volume, Value and Sales Price)

8.1 India T-Cell Immunotherapy Sales and Value (2012-2017)

8.1.1 India T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

8.1.2 India T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

8.1.3 India T-Cell Immunotherapy Sales Price Trend (2012-2017)

8.2 India T-Cell Immunotherapy Sales and Market Share by Manufacturers

8.3 India T-Cell Immunotherapy Sales and Market Share by Type

8.4 India T-Cell Immunotherapy Sales and Market Share by Application

9 Global T-Cell Immunotherapy Manufacturers Analysis

9.1 Adaptimmune

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 T-Cell Immunotherapy Product Type, Application and Specification

9.1.2.1 CAR-T

9.1.2.2 TCR

9.1.3 Adaptimmune T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

9.1.4 Main Business/Business Overview

9.2 Altor Bioscience Corporation

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 T-Cell Immunotherapy Product Type, Application and Specification

9.2.2.1 CAR-T

9.2.2.2 TCR

9.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

9.2.4 Main Business/Business Overview

9.3 Cellectis

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 T-Cell Immunotherapy Product Type, Application and Specification

9.3.2.1 CAR-T

9.3.2.2 TCR

9.3.3 Cellectis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

9.3.4 Main Business/Business Overview

9.4 Cell Therapy Catapult

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 T-Cell Immunotherapy Product Type, Application and Specification

9.4.2.1 CAR-T

9.4.2.2 TCR

9.4.3 Cell Therapy Catapult T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

9.4.4 Main Business/Business Overview

9.5 Juno Therapeutics

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 T-Cell Immunotherapy Product Type, Application and Specification

9.5.2.1 CAR-T

9.5.2.2 TCR

9.5.3 Juno Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

9.5.4 Main Business/Business Overview

9.6 Kite Pharma

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 T-Cell Immunotherapy Product Type, Application and Specification

9.6.2.1 CAR-T

9.6.2.2 TCR

9.6.3 Kite Pharma T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

9.6.4 Main Business/Business Overview

9.7 Novartis

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 T-Cell Immunotherapy Product Type, Application and Specification

9.7.2.1 CAR-T

9.7.2.2 TCR

9.7.3 Novartis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

9.7.4 Main Business/Business Overview

9.8 Takara Bio

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 T-Cell Immunotherapy Product Type, Application and Specification

9.8.2.1 CAR-T

9.8.2.2 TCR

9.8.3 Takara Bio T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

9.8.4 Main Business/Business Overview

9.9 Unum Therapeutics

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 T-Cell Immunotherapy Product Type, Application and Specification

9.9.2.1 CAR-T

9.9.2.2 TCR

9.9.3 Unum Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

9.9.4 Main Business/Business Overview

9.10 Abingworth

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 T-Cell Immunotherapy Product Type, Application and Specification

9.10.2.1 CAR-T

9.10.2.2 TCR

9.10.3 Abingworth T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

9.10.4 Main Business/Business Overview

9.11 ARCH Venture Partners

9.12 Acorn Campus Ventures

9.13 Adaptimmune

9.14 AFA F?rs?kring

9.15 AGF Private Equity

9.16 AgonOx

9.17 Agreen Biotech

9.18 Aju IB Investment

9.19 Alaska Permanent Fund

9.20 Alexandria Ventures

9.21 Allos Therapeutics

9.22 Amgen

9.23 Applied Immune Technologies

9.24 Aquilo Capital Management

10 T-Cell Immunotherapy Maufacturing Cost Analysis

10.1 T-Cell Immunotherapy Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of T-Cell Immunotherapy

10.3 Manufacturing Process Analysis of T-Cell Immunotherapy

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 T-Cell Immunotherapy Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of T-Cell Immunotherapy Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global T-Cell Immunotherapy Market Forecast (2017-2022)

14.1 Global T-Cell Immunotherapy Sales, Revenue and Price Forecast (2017-2022)

14.1.1 Global T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)

14.1.2 Global T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)

14.1.3 Global T-Cell Immunotherapy Price and Trend Forecast (2017-2022)

14.2 Global T-Cell Immunotherapy Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)

14.2.1 United States T-Cell Immunotherapy Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.2 China T-Cell Immunotherapy Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.3 Europe T-Cell Immunotherapy Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.4 Japan T-Cell Immunotherapy Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.5 Southeast Asia T-Cell Immunotherapy Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.6 India T-Cell Immunotherapy Sales, Revenue and Growth Rate Forecast (2017-2022)

14.3 Global T-Cell Immunotherapy Sales, Revenue and Price Forecast by Type (2017-2022)

14.4 Global T-Cell Immunotherapy Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of T-Cell Immunotherapy

Table Classification of T-Cell Immunotherapy

Figure Global Sales Market Share of T-Cell Immunotherapy by Type in 2015

Figure CAR-T Picture

Figure TCR Picture

Figure TIL Therapies Picture

Table Applications of T-Cell Immunotherapy

Figure Global Sales Market Share of T-Cell Immunotherapy by Application in 2015

Figure Hematological Malignancies Examples

Figure Solid Tumors Examples

Figure Others Examples

Figure United States T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Figure China T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Figure Europe T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Figure Japan T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Figure Southeast Asia T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Figure India T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Figure Global T-Cell Immunotherapy Sales and Growth Rate (2012-2022)

Figure Global T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Table Global T-Cell Immunotherapy Sales of Key Manufacturers (2012-2017)

Table Global T-Cell Immunotherapy Sales Share by Manufacturers (2012-2017)

Figure 2015 T-Cell Immunotherapy Sales Share by Manufacturers

Figure 2016 T-Cell Immunotherapy Sales Share by Manufacturers

Table Global T-Cell Immunotherapy Revenue by Manufacturers (2012-2017)

Table Global T-Cell Immunotherapy Revenue Share by Manufacturers (2012-2017)

Table 2015 Global T-Cell Immunotherapy Revenue Share by Manufacturers

Table 2016 Global T-Cell Immunotherapy Revenue Share by Manufacturers

Table Global T-Cell Immunotherapy Sales and Market Share by Type (2012-2017)

Table Global T-Cell Immunotherapy Sales Share by Type (2012-2017)

Figure Sales Market Share of T-Cell Immunotherapy by Type (2012-2017)

Figure Global T-Cell Immunotherapy Sales Growth Rate by Type (2012-2017)

Table Global T-Cell Immunotherapy Revenue and Market Share by Type (2012-2017)

Table Global T-Cell Immunotherapy Revenue Share by Type (2012-2017)

Figure Revenue Market Share of T-Cell Immunotherapy by Type (2012-2017)

Figure Global T-Cell Immunotherapy Revenue Growth Rate by Type (2012-2017)

Table Global T-Cell Immunotherapy Sales and Market Share by Regions (2012-2017)

Table Global T-Cell Immunotherapy Sales Share by Regions (2012-2017)

Figure Sales Market Share of T-Cell Immunotherapy by Regions (2012-2017)

Figure Global T-Cell Immunotherapy Sales Growth Rate by Regions (2012-2017)

Table Global T-Cell Immunotherapy Revenue and Market Share by Regions (2012-2017)

Table Global T-Cell Immunotherapy Revenue Share by Regions (2012-2017)

Figure Revenue Market Share of T-Cell Immunotherapy by Regions (2012-2017)

Figure Global T-Cell Immunotherapy Revenue Growth Rate by Regions (2012-2017)

Table Global T-Cell Immunotherapy Sales and Market Share by Application (2012-2017)

Table Global T-Cell Immunotherapy Sales Share by Application (2012-2017)

Figure Sales Market Share of T-Cell Immunotherapy by Application (2012-2017)

Figure Global T-Cell Immunotherapy Sales Growth Rate by Application (2012-2017)

Figure United States T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

Figure United States T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

Figure United States T-Cell Immunotherapy Sales Price Trend (2012-2017)

Table United States T-Cell Immunotherapy Sales by Manufacturers (2012-2017)

Table United States T-Cell Immunotherapy Market Share by Manufacturers (2012-2017)

Table United States T-Cell Immunotherapy Sales by Type (2012-2017)

Table United States T-Cell Immunotherapy Market Share by Type (2012-2017)

Table United States T-Cell Immunotherapy Sales by Application (2012-2017)

Table United States T-Cell Immunotherapy Market Share by Application (2012-2017)

Figure China T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

Figure China T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

Figure China T-Cell Immunotherapy Sales Price Trend (2012-2017)

Table China T-Cell Immunotherapy Sales by Manufacturers (2012-2017)

Table China T-Cell Immunotherapy Market Share by Manufacturers (2012-2017)

Table China T-Cell Immunotherapy Sales by Type (2012-2017)

Table China T-Cell Immunotherapy Market Share by Type (2012-2017)

Table China T-Cell Immunotherapy Sales by Application (2012-2017)

Table China T-Cell Immunotherapy Market Share by Application (2012-2017)

Figure Europe T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

Figure Europe T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

Figure Europe T-Cell Immunotherapy Sales Price Trend (2012-2017)

Table Europe T-Cell Immunotherapy Sales by Manufacturers (2012-2017)

Table Europe T-Cell Immunotherapy Market Share by Manufacturers (2012-2017)

Table Europe T-Cell Immunotherapy Sales by Type (2012-2017)

Table Europe T-Cell Immunotherapy Market Share by Type (2012-2017)

Table Europe T-Cell Immunotherapy Sales by Application (2012-2017)

Table Europe T-Cell Immunotherapy Market Share by Application (2012-2017)

Figure Japan T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

Figure Japan T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

Figure Japan T-Cell Immunotherapy Sales Price Trend (2012-2017)

Table Japan T-Cell Immunotherapy Sales by Manufacturers (2012-2017)

Table Japan T-Cell Immunotherapy Market Share by Manufacturers (2012-2017)

Table Japan T-Cell Immunotherapy Sales by Type (2012-2017)

Table Japan T-Cell Immunotherapy Market Share by Type (2012-2017)

Table Japan T-Cell Immunotherapy Sales by Application (2012-2017)

Table Japan T-Cell Immunotherapy Market Share by Application (2012-2017)

Figure Southeast Asia T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

Figure Southeast Asia T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

Figure Southeast Asia T-Cell Immunotherapy Sales Price Trend (2012-2017)

Table Southeast Asia T-Cell Immunotherapy Sales by Manufacturers (2012-2017)

Table Southeast Asia T-Cell Immunotherapy Market Share by Manufacturers (2012-2017)

Table Southeast Asia T-Cell Immunotherapy Sales by Type (2012-2017)

Table Southeast Asia T-Cell Immunotherapy Market Share by Type (2012-2017)

Table Southeast Asia T-Cell Immunotherapy Sales by Application (2012-2017)

Table Southeast Asia T-Cell Immunotherapy Market Share by Application (2012-2017)

Figure India T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

Figure India T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

Figure India T-Cell Immunotherapy Sales Price Trend (2012-2017)

Table India T-Cell Immunotherapy Sales by Manufacturers (2012-2017)

Table India T-Cell Immunotherapy Market Share by Manufacturers (2012-2017)

Table India T-Cell Immunotherapy Sales by Type (2012-2017)

Table India T-Cell Immunotherapy Market Share by Type (2012-2017)

Table India T-Cell Immunotherapy Sales by Application (2012-2017)

Table India T-Cell Immunotherapy Market Share by Application (2012-2017)

Table Adaptimmune Basic Information List

Table Adaptimmune T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Adaptimmune T-Cell Immunotherapy Global Market Share (2012-2017)

Table Altor Bioscience Corporation Basic Information List

Table Altor Bioscience Corporation T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Altor Bioscience Corporation T-Cell Immunotherapy Global Market Share (2012-2017)

Table Cellectis Basic Information List

Table Cellectis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Cellectis T-Cell Immunotherapy Global Market Share (2012-2017)

Table Cell Therapy Catapult Basic Information List

Table Cell Therapy Catapult T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Cell Therapy Catapult T-Cell Immunotherapy Global Market Share (2012-2017)

Table Juno Therapeutics Basic Information List

Table Juno Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Juno Therapeutics T-Cell Immunotherapy Global Market Share (2012-2017)

Table Kite Pharma Basic Information List

Table Kite Pharma T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Kite Pharma T-Cell Immunotherapy Global Market Share (2012-2017)

Table Novartis Basic Information List

Table Novartis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Novartis T-Cell Immunotherapy Global Market Share (2012-2017)

Table Takara Bio Basic Information List

Table Takara Bio T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Takara Bio T-Cell Immunotherapy Global Market Share (2012-2017)

Table Unum Therapeutics Basic Information List

Table Unum Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Unum Therapeutics T-Cell Immunotherapy Global Market Share (2012-2017)

Table Abingworth Basic Information List

Table Abingworth T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Abingworth T-Cell Immunotherapy Global Market Share (2012-2017)

Table ARCH Venture Partners Basic Information List

Table Acorn Campus Ventures Basic Information List

Table Adaptimmune Basic Information List

Table AFA F?rs?kring Basic Information List

Table AGF Private Equity Basic Information List

Table AgonOx Basic Information List

Table Agreen Biotech Basic Information List

Table Aju IB Investment Basic Information List

Table Alaska Permanent Fund Basic Information List

Table Alexandria Ventures Basic Information List

Table Allos Therapeutics Basic Information List

Table Amgen Basic Information List

Table Applied Immune Technologies Basic Information List

Table Aquilo Capital Management Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of T-Cell Immunotherapy

Figure Manufacturing Process Analysis of T-Cell Immunotherapy

Figure T-Cell Immunotherapy Industrial Chain Analysis

Table Raw Materials Sources of T-Cell Immunotherapy Major Manufacturers in 2015

Table Major Buyers of T-Cell Immunotherapy

Table Distributors/Traders List

Figure Global T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)

Figure Global T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)

Table Global T-Cell Immunotherapy Sales Forecast by Regions (2017-2022)

Table Global T-Cell Immunotherapy Sales Forecast by Type (2017-2022)

Table Global T-Cell Immunotherapy Sales Forecast by Application (2017-2022)